Elevance Health, Inc. (ELV)
NYSE: ELV · Real-Time Price · USD
397.48
+3.28 (0.83%)
Nov 20, 2024, 4:00 PM EST - Market closed
Elevance Health Revenue
Elevance Health had revenue of $45.15B in the quarter ending September 30, 2024, with 5.36% growth. This brings the company's revenue in the last twelve months to $174.02B, up 3.20% year-over-year. In the year 2023, Elevance Health had annual revenue of $171.34B with 9.41% growth.
Revenue (ttm)
$174.02B
Revenue Growth
+3.20%
P/S Ratio
0.53
Revenue / Employee
$1,658,866
Employees
104,900
Market Cap
92.18B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 171.34B | 14.74B | 9.41% |
Dec 31, 2022 | 156.60B | 17.96B | 12.95% |
Dec 31, 2021 | 138.64B | 16.78B | 13.76% |
Dec 31, 2020 | 121.87B | 17.66B | 16.94% |
Dec 31, 2019 | 104.21B | 12.12B | 13.16% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
McKesson | 330.19B |
The Cigna Group | 229.75B |
HCA Healthcare | 69.62B |
Sanofi | 54.03B |
Bristol-Myers Squibb Company | 47.44B |
Medtronic | 32.58B |
Gilead Sciences | 28.30B |
Regeneron Pharmaceuticals | 13.85B |
ELV News
- 2 days ago - Elevance Health, Inc. Shareholders are Encouraged to Reach Out to Johnson Fistel for More Information about Potentially Recovering Their Losses - GlobeNewsWire
- 5 days ago - Elevance Health, Inc. (ELV) UBS Global Healthcare Conference (Transcript) - Seeking Alpha
- 12 days ago - Trump Win Gives Some U.S. Health Insurers A Post-Election Bump On Wall Street - Seeking Alpha
- 13 days ago - Elevance Health, Inc. Shareholders are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses - GlobeNewsWire
- 15 days ago - Elevance Health Announces Appearance at UBS Global Healthcare Conference - Business Wire
- 16 days ago - Elevance Health Appoints Nathan Rich Vice President, Investor Relations - Business Wire
- 17 days ago - My Top 15 High-Growth Dividend Stocks For November 2024 - Seeking Alpha
- 20 days ago - These are the S&P 500's biggest laggards for October, down by as much as 29% - Market Watch